• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

液质联用方法测定依伐卡托和卢美卡托中潜在遗传毒性杂质的痕量。

Liquid chromatography-mass spectrometric methods for trace quantification of potential genotoxic impurities in ivacaftor and lumacaftor.

机构信息

Department of Chemistry, BITS-Pilani Hyderabad Campus, Jawaharnagar, Hyderabad, Medchal (Dist), Telangana 500078, India.

Department of Pharmacy, BITS-Pilani Hyderabad Campus, Jawaharnagar, Hyderabad, Medchal (Dist), Telangana 500078, India.

出版信息

Ann Pharm Fr. 2022 Jul;80(4):448-459. doi: 10.1016/j.pharma.2021.11.005. Epub 2021 Dec 9.

DOI:10.1016/j.pharma.2021.11.005
PMID:34896381
Abstract

OBJECTIVE

The objective of the current study was to develop and validate the sensitive LC-MS methods for trace analysis of genotoxic impurities in Ivacaftor and Lumacaftor. The first method is for the trace analysis of 2,4-di-tert-butyl-5-nitrophenol in ivacaftor and the second method is for the trace analysis of 1-(2,2-difluoro-1,3-benzodioxol-5yl)-cyclopropane carboxylic acid and 3-carboxyphenyl boronic acid in lumacaftor.

MATERIALS AND METHODS

High pure analytical grade solvents and reagents were used for this study. The chromatographic separation was performed on Luna C18 (250×4.6mm, 5.0μm) at a column temperature of 25°C using eluent consisting of acetonitrile and 0.1% v/v formic acid in water in a gradient elution mode. The eluent was run at a flow of 1.0mL/min and injection volume of 20μL.

RESULTS

The linearity, precision and accuracy of the developed methods was validated over the concentration range of 0.35-15.0ppm for 2,4-di-tert-butyl-5-nitrophenol, 0.30-15.0ppm for 1-(2,2-difluoro-1,3-benzodioxol-5yl)-cyclopropane carboxylic acid and 0.23-15.0ppm for 3-carboxyphenyl boronic acid. In both methods, interference was not observed at the retention time of analyte peaks. All the analytes were found to be stable in solution for a period of 48h.

CONCLUSION

The proposed methods are reliable, sensitive, precise, accurate, and robust for the trace level quantification of genotoxic impurities in Ivacaftor and Lumacaftor. These methods can be successfully implemented in the quality control lab for routine analysis.

摘要

目的

本研究旨在开发和验证灵敏的 LC-MS 方法,用于痕量分析伊伐卡托和卢美卡托中的遗传毒性杂质。第一种方法用于痕量分析伊伐卡托中的 2,4-二叔丁基-5-硝基苯酚,第二种方法用于痕量分析卢美卡托中的 1-(2,2-二氟-1,3-苯并二氧戊环-5-基)-环丙烷羧酸和 3-羧基苯硼酸。

材料与方法

本研究使用高纯分析级溶剂和试剂。色谱分离在 Luna C18(250×4.6mm,5.0μm)柱上进行,柱温为 25°C,洗脱剂为乙腈和 0.1%v/v 甲酸水溶液,采用梯度洗脱模式。洗脱液流速为 1.0mL/min,进样量为 20μL。

结果

在 2,4-二叔丁基-5-硝基苯酚的浓度范围为 0.35-15.0ppm、1-(2,2-二氟-1,3-苯并二氧戊环-5-基)-环丙烷羧酸的浓度范围为 0.30-15.0ppm、3-羧基苯硼酸的浓度范围为 0.23-15.0ppm 时,所建立的方法具有良好的线性、精密度和准确度。在两种方法中,在分析物峰的保留时间处均未观察到干扰。所有分析物在溶液中 48h 内均稳定。

结论

所提出的方法可靠、灵敏、精确、准确、稳健,可用于痕量定量分析伊伐卡托和卢美卡托中的遗传毒性杂质。这些方法可成功应用于质量控制实验室进行常规分析。

相似文献

1
Liquid chromatography-mass spectrometric methods for trace quantification of potential genotoxic impurities in ivacaftor and lumacaftor.液质联用方法测定依伐卡托和卢美卡托中潜在遗传毒性杂质的痕量。
Ann Pharm Fr. 2022 Jul;80(4):448-459. doi: 10.1016/j.pharma.2021.11.005. Epub 2021 Dec 9.
2
Development of HPLC and LC-MS/MS methods for the analysis of ivacaftor, its major metabolites and lumacaftor in plasma and sputum of cystic fibrosis patients treated with ORKAMBI or KALYDECO.开发用于分析接受ORKAMBI或KALYDECO治疗的囊性纤维化患者血浆和痰液中依伐卡托、其主要代谢物及鲁马卡托的高效液相色谱法和液相色谱-串联质谱法。
J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Dec 1;1038:57-62. doi: 10.1016/j.jchromb.2016.10.026. Epub 2016 Oct 24.
3
Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients.用于囊性纤维化患者生物体液中依伐卡托及其主要代谢物和鲁马卡托临床样本高通量分析的优化液相色谱-串联质谱法
J Vis Exp. 2017 Oct 15(128):56084. doi: 10.3791/56084.
4
A sensitive LC-MS/MS method for the determination of potential genotoxic impurities in Cinnarizine.
Ann Pharm Fr. 2023 Jan;81(1):74-82. doi: 10.1016/j.pharma.2022.06.010. Epub 2022 Jul 2.
5
Trace-level determination of potential genotoxic impurities in quetiapine fumarate using LC-MS.采用液相色谱-质谱联用技术对富马酸喹硫平中潜在的基因毒性杂质进行痕量测定。
Biomed Chromatogr. 2023 Apr;37(4):e5575. doi: 10.1002/bmc.5575. Epub 2023 Jan 3.
6
Liquid chromatographic determination of lumacaftor in the presence of ivacaftor and identification of five novel degradation products using high-performance liquid chromatography ion trap time-of-flight mass spectrometry.在依伐卡托存在的情况下,采用高效液相色谱法测定鲁马卡托,并使用高效液相色谱离子阱飞行时间质谱法鉴定五种新型降解产物。
J Sep Sci. 2023 Sep;46(17):e2300228. doi: 10.1002/jssc.202300228. Epub 2023 Jul 6.
7
Metabolomic responses to lumacaftor/ivacaftor in cystic fibrosis.囊性纤维化中 lumacaftor/ivacaftor 的代谢组学反应。
Pediatr Pulmonol. 2018 May;53(5):583-591. doi: 10.1002/ppul.23972. Epub 2018 Feb 20.
8
Efficacy and safety of lumacaftor/ivacaftor combination therapy in patients with cystic fibrosis homozygous for Phe508del CFTR by pulmonary function subgroup: a pooled analysis.依库珠单抗/ivacaftor 联合治疗对肺功能亚组纯合子 Phe508del CFTR 囊性纤维化患者的疗效和安全性:一项汇总分析。
Lancet Respir Med. 2016 Aug;4(8):617-626. doi: 10.1016/S2213-2600(16)30121-7. Epub 2016 Jun 10.
9
Efficacy and safety of lumacaftor and ivacaftor in patients aged 6-11 years with cystic fibrosis homozygous for F508del-CFTR: a randomised, placebo-controlled phase 3 trial.在 F508del-CFTR 纯合子的 6-11 岁囊性纤维化患者中, lumacaftor 和 ivacaftor 的疗效和安全性:一项随机、安慰剂对照的 3 期临床试验。
Lancet Respir Med. 2017 Jul;5(7):557-567. doi: 10.1016/S2213-2600(17)30215-1. Epub 2017 Jun 9.
10
Assessment of safety and efficacy of long-term treatment with combination lumacaftor and ivacaftor therapy in patients with cystic fibrosis homozygous for the F508del-CFTR mutation (PROGRESS): a phase 3, extension study.评估长期使用组合 Lumacaftor 和 Ivacaftor 疗法治疗囊性纤维化纯合子 F508del-CFTR 突变患者的安全性和疗效(PROGRESS):一项 3 期扩展研究。
Lancet Respir Med. 2017 Feb;5(2):107-118. doi: 10.1016/S2213-2600(16)30427-1. Epub 2016 Dec 21.